October 9, 2018
Authored and Edited by Matthew J. Luneack; M. Andrew Holtman, Ph.D.
In University of California v. Broad Institute, Inc., No. 2017-1907 (Fed. Cir. Sept. 10, 2018), the CAFC affirmed the PTAB’s holding that there was no interference-in-fact between a pending University of California patent application and the claims of twelve patents and one application owned by Broad. The PTAB had found that Broad’s claims directed to the use of a CRISPR-Cas9 system in eukaryotic cells were separately patentable over the University of California’s claims that did not refer to a particular cell type or environment. On appeal, the CAFC held the PTAB had properly considered the lack of specific instructions in the prior art describing how to apply CRISPR-Cas9 in eukaryotic cells in conjunction with additional evidence supporting the PTAB’s determination. Further discussion of the decision can be found on Finnegan’s Federal Circuit IP Blog.
Copyright © 2018 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
INCONTESTABLE® Blog
The Federal Circuit’s Heartfelt Affirmation of Everybody’s Right to Use “Everybody vs. Racism”
March 22, 2024
Hybrid Conference
California Intellectual Property Law Institute 2023
November 2-3, 2023
San Francisco
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.